What ASCO 2026’s “Translation” Theme Actually Means When You’re Running a Phase I Oncology Trial

Read article

Common Causes of Delays in Immuno-Oncology Studies

It’s common for “standard” oncology studies to encounter…
Read Article

Challenges with Checkpoint Inhibitors in the Clinic

Checkpoint inhibitors, including those targeting PD-1 and PD-L1,…
Read Article

The #1 Reason Why Oncology Studies Finish Late and Over Budget

Everyone in clinical research understands the importance of…
Read Article

Join Medelis at ASCO 2019

The ASCO 2019 Annual Meeting takes place May…
Read Article

Case Study: Phase III Rescue of a Global Trial

An existing client requested Medelis to take over…
Read Article

Bispecific Antibody Treatments, AML & Immunotherapy Treatments

With the ASH 2018 annual meeting right around…
Read Article

Case Study: Oncology Expert Review of Clinical Data

A top 5 pharmaceutical company had a severe…
Read Article

Case Study: Accelerated Completion of a Cancer Vaccine Trial

A US client contracted Medelis to conduct a…
Read Article

ASCO 2018

The ASCO 2018 Annual Meeting takes place June…
Read Article